Capricor Therapeutics, Inc. (CAPR) Social Stream
CAPRICOR THERAPEUTICS INC (CAPR) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering CAPRICOR THERAPEUTICS INC.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
CAPR's average price target has moved down $0 over the prior 40 weeks.
CAPR reports an average of 228.86% for its upside potential over the past 45 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
CAPR Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
CAPR's average broker recommendation rating improved by 1 over the prior 19 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CAPR as an investment opportunity.
- In terms of how CAPRICOR THERAPEUTICS INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 14.82% of that group.
- In terms of how CAPRICOR THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 256.95% of that group.
- In terms of how CAPRICOR THERAPEUTICS INC fares relative to all US stocks, note that its average analyst price target is greater than 51.85% of that group.
- In the context of Pharmaceutical Products stocks, CAPRICOR THERAPEUTICS INC's variance in analysts' estimates is lower than 42.3% of them.
Stocks similar to CAPRICOR THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are KTRA, ATXI, and LPTX.
View All Top Stocks by Price Target
Make investment decisions regarding CAPR using the data that counts. Try POWR Ratings for free.